Orion Genomics Announces Notice Of Allowance For US Patent Covering Genome Wide Novel Biomarker Discovery Platform
20-Nov-2006
Orion's MethylScope technology, exclusively licensed from CSHL, is, according to the company, the only platform capable of detecting inappropriate DNA methylation for all human genes on a single array, providing an efficient and comprehensive biomarker discovery tool. By comparing methylation profiles, Orion discovers new biomarkers associated with specific diseases.
Most read news
Organizations
Orion Genomics
Centre National de la Recherche Scientifique
Cold Spring Harbor Laboratory
Other news from the department research and development
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.